Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study

OBJECTIVE: To evaluate the effectiveness and safety of nab-paclitaxel plus platinum as first-line chemotherapy for ovarian cancer (OC). METHODS: Patients administered platinum combined with nab-paclitaxel as first-line chemotherapy for epithelial OC, fallopian tube cancer, or primary peritoneal canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liangliang, Li, Shuangying, Zhu, Da, Qin, Yu, Wang, Xiaoli, Hong, Zhenya, Han, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323297/
https://www.ncbi.nlm.nih.gov/pubmed/36807747
http://dx.doi.org/10.3802/jgo.2023.34.e44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323297/
https://www.ncbi.nlm.nih.gov/pubmed/36807747
http://dx.doi.org/10.3802/jgo.2023.34.e44

Ejemplares similares